This month's Digestive Diseases & Sciences examines primary care physician perspectives on Hep C management in the era of direct-acting antiviral therapy.
Cardiovascular risk reduction in patients with nonalcoholic fatty liver disease using ezetimibe, reports the latest issue of the Digestive Diseases & Sciences.
November's Journal of Gastroenterology performed a population-based study examining the risk of malignancy in patients diagnosed with inflammatory bowel disease.
November's publication of the Annals of Internal Medicine examines the use of elbasvir–grazoprevir to treat Hepatitis C virus infection in persons receiving opioid agonist therapy.
Diabetes mellitus heightens the risk of hepatocellular carcinoma except in patients with Hepatitis C cirrhosis, reports November's American Journal of Gastroenterology.
Low serum testosterone is associated with adverse outcome in men with cirrhosis independent of the model for end-stage liver disease score, reports the most recent issue of Liver Transplantation.
This month's Annals of Internal Medicine evaluates the effect of fecal microbiota transplantation on recurrence in multiple recurrent Clostridium difficile infections.
This month's American Journal of Gastroenterology examines the effect of a video on diet before outpatient colonoscopy and the subsequent quality of bowel preparation.
A study in November's issue of the American Journal of Gastroenterology examines the impact on endoscopic resource utilization after a targeted intervention for cost-minimization of esophagogastroduodenoscopy, and colonoscopy.
Published ahead of print, a study in the Alimentary Pharmacology & Therapeutics investigates the risk of incident Mycobacterium tuberculosis infection in patients with inflammatory bowel disease.
The most recent issue of Liver Transplantation reviews a 10-year united network for organ sharing of mortality and risk factors in young children under 2 years of age awaiting liver transplantation.
Nonsteroidal anti-inflammatory drug use is not associated with reduced risk of Barrett’s esophagus, reports November's issue of the American Journal of Gastroenterology.
Our site uses cookies to improve your experience.You can find out more about our use of cookies in our standard cookie policy, including instructions on how to reject and delete cookies if you wish to do so.
By continuing to browse this site you agree to us using cookies as described in our
standard cookie policy .